With the severe disruption to research activity due to the COVID-19 pandemic causing strain at labs across the country, the National Institutes of Health (NIH) has had to quickly address the situation for the workforce while also mobilizing to support research activities related to the virus and comorbidities. Despite the extreme challenge of the situation,...
Author: Mark Newman
As the pandemic took hold in the U.S. and communities implemented strict social distancing measures, including stay-at-home orders, the Endocrine Society pivoted its advocacy approach to Congress and launched a strategic “virtual” Hill Day to advocate our recommendations for relief legislation. Originally, the Society had planned a Hill Day for April 20 to bring members...
In the past couple of months, I have been in awe at the way in which our organization has responded during this unprecedented pandemic that has and will continue to change how we do what we do – personally and professionally. The Endocrine Society is adapting and will continue to rise to the challenges of...
Carol A. Lange, PhD, professor of medicine at the University of Minnesota in Minneapolis, Minn., has been named editor-in-chief of Endocrinology, the flagship basic science journal of the Endocrine Society. “I’m honored to join Endocrinology’s mission to be the leading source of emerging hormone science and to share this knowledge in a meaningful way with scientists, clinicians and the public,” Lange says. “I’ve dedicated my...
Fresh from receiving his 2020 Laureate Award for Outstanding Innovation, Christopher B. Newgard, PhD, discusses how collaboration has shaped his research and why he focuses on metabolomics to unlock the mysteries of cardiometabolic diseases. Christopher B. Newgard, PhD, does not hesitate to give credit to the many mentors and colleagues who have inspired his... As the COVID-19 virus has spread around the world, more and more people are told to work from home. That includes scientists, researchers, lab techs, PhD students, and others who have had to leave the bench behind. Endocrine News reached out to researchers and basic scientists to see how life in their labs has changed,...
Viral Load: A Look at One Endocrinologist’s Practice During the COVID-19 Crisis
Via an online video conference with Endocrine News, Mihail “Misha” Zilbermint, MD, discusses how the COVID-19 virus has changed the way he practices medicine in a hospital setting, and how his approach to treating patients may be changed forever. One of the common terms that has been used to describe everything from the way...Revised ADA Guidelines Include SGLT2 Inhibitors for Type 2 Diabetes Patients
SGLT2 inhibitors were designed to lower glucose, but clinical trials uncovered unexpected cardiovascular and renal benefits. Updated guidelines from the American Diabetes Association now recommends SGLT2 inhibitors in type 2 diabetes patients to lower glucose. The evidence is clear that SGLT2 inhibitors should be added to the drug regimen of many type 2 diabetes patients,...
